nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP1A1—breast cancer	0.0973	0.343	CbGaD
Fluvoxamine—CYP2D6—breast cancer	0.0724	0.255	CbGaD
Fluvoxamine—CYP3A4—breast cancer	0.0621	0.219	CbGaD
Fluvoxamine—ABCB1—breast cancer	0.0517	0.182	CbGaD
Fluvoxamine—SIGMAR1—Raloxifene—breast cancer	0.0423	0.0905	CbGbCtD
Fluvoxamine—SIGMAR1—Tamoxifen—breast cancer	0.0279	0.0598	CbGbCtD
Fluvoxamine—CYP1A1—Toremifene—breast cancer	0.0271	0.0581	CbGbCtD
Fluvoxamine—CYP2B6—Thiotepa—breast cancer	0.0171	0.0367	CbGbCtD
Fluvoxamine—CYP1A2—Anastrozole—breast cancer	0.0132	0.0284	CbGbCtD
Fluvoxamine—CYP1A2—Toremifene—breast cancer	0.0121	0.0259	CbGbCtD
Fluvoxamine—CYP2C9—Anastrozole—breast cancer	0.0119	0.0256	CbGbCtD
Fluvoxamine—CYP3A5—Lapatinib—breast cancer	0.0119	0.0254	CbGbCtD
Fluvoxamine—CYP2B6—Raloxifene—breast cancer	0.0114	0.0245	CbGbCtD
Fluvoxamine—ABCB1—Toremifene—breast cancer	0.0106	0.0227	CbGbCtD
Fluvoxamine—CYP1A1—Tamoxifen—breast cancer	0.00991	0.0212	CbGbCtD
Fluvoxamine—CYP2C19—Lapatinib—breast cancer	0.00958	0.0205	CbGbCtD
Fluvoxamine—CYP3A4—Exemestane—breast cancer	0.00916	0.0196	CbGbCtD
Fluvoxamine—CYP2C9—Idarubicin—breast cancer	0.00905	0.0194	CbGbCtD
Fluvoxamine—CYP2D6—Idarubicin—breast cancer	0.00827	0.0177	CbGbCtD
Fluvoxamine—CYP3A7—Tamoxifen—breast cancer	0.00793	0.017	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00793	0.017	CbGbCtD
Fluvoxamine—CYP3A4—Letrozole—breast cancer	0.00779	0.0167	CbGbCtD
Fluvoxamine—ABCB1—Lapatinib—breast cancer	0.00773	0.0166	CbGbCtD
Fluvoxamine—CYP2E1—Tamoxifen—breast cancer	0.00765	0.0164	CbGbCtD
Fluvoxamine—CYP2B6—Tamoxifen—breast cancer	0.00755	0.0162	CbGbCtD
Fluvoxamine—CYP2E1—Mitoxantrone—breast cancer	0.00746	0.016	CbGbCtD
Fluvoxamine—CYP3A4—Anastrozole—breast cancer	0.00694	0.0149	CbGbCtD
Fluvoxamine—CYP3A4—Toremifene—breast cancer	0.00635	0.0136	CbGbCtD
Fluvoxamine—CYP3A7—Paclitaxel—breast cancer	0.00617	0.0132	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00617	0.0132	CbGbCtD
Fluvoxamine—CYP3A7—Irinotecan—breast cancer	0.00609	0.013	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00609	0.013	CbGbCtD
Fluvoxamine—CYP3A5—Tamoxifen—breast cancer	0.00595	0.0127	CbGbCtD
Fluvoxamine—CYP3A4—Fulvestrant—breast cancer	0.0059	0.0126	CbGbCtD
Fluvoxamine—CYP2B6—Irinotecan—breast cancer	0.0058	0.0124	CbGbCtD
Fluvoxamine—CYP3A4—Thiotepa—breast cancer	0.00526	0.0113	CbGbCtD
Fluvoxamine—CYP2C9—Capecitabine—breast cancer	0.00496	0.0106	CbGbCtD
Fluvoxamine—CYP3A4—Ixabepilone—breast cancer	0.00481	0.0103	CbGbCtD
Fluvoxamine—CYP2C19—Tamoxifen—breast cancer	0.0048	0.0103	CbGbCtD
Fluvoxamine—CYP3A4—Lapatinib—breast cancer	0.00463	0.00992	CbGbCtD
Fluvoxamine—CYP3A5—Paclitaxel—breast cancer	0.00463	0.00991	CbGbCtD
Fluvoxamine—CYP3A5—Irinotecan—breast cancer	0.00457	0.00978	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00446	0.00955	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—breast cancer	0.00446	0.00955	CbGbCtD
Fluvoxamine—CYP1A2—Tamoxifen—breast cancer	0.00443	0.00948	CbGbCtD
Fluvoxamine—ABCB1—Vinorelbine—breast cancer	0.00429	0.00918	CbGbCtD
Fluvoxamine—CYP2D6—Vinorelbine—breast cancer	0.00404	0.00865	CbGbCtD
Fluvoxamine—CYP2C9—Tamoxifen—breast cancer	0.00399	0.00854	CbGbCtD
Fluvoxamine—ABCB1—Tamoxifen—breast cancer	0.00387	0.00829	CbGbCtD
Fluvoxamine—ABCB1—Mitoxantrone—breast cancer	0.00377	0.00808	CbGbCtD
Fluvoxamine—CYP2D6—Tamoxifen—breast cancer	0.00365	0.00781	CbGbCtD
Fluvoxamine—CYP3A4—Raloxifene—breast cancer	0.00351	0.00752	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—breast cancer	0.00335	0.00717	CbGbCtD
Fluvoxamine—ABCB1—Gemcitabine—breast cancer	0.00333	0.00714	CbGbCtD
Fluvoxamine—CYP1A2—Fluorouracil—breast cancer	0.00326	0.00698	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—breast cancer	0.00317	0.00678	CbGbCtD
Fluvoxamine—CYP2C9—Paclitaxel—breast cancer	0.0031	0.00665	CbGbCtD
Fluvoxamine—ABCB1—Paclitaxel—breast cancer	0.00301	0.00645	CbGbCtD
Fluvoxamine—ABCB1—Irinotecan—breast cancer	0.00297	0.00636	CbGbCtD
Fluvoxamine—CYP2C9—Fluorouracil—breast cancer	0.00294	0.00629	CbGbCtD
Fluvoxamine—ABCB1—Vinblastine—breast cancer	0.00264	0.00566	CbGbCtD
Fluvoxamine—CYP3A4—Vinorelbine—breast cancer	0.00257	0.0055	CbGbCtD
Fluvoxamine—CYP2D6—Vinblastine—breast cancer	0.00249	0.00533	CbGbCtD
Fluvoxamine—CYP3A4—Tamoxifen—breast cancer	0.00232	0.00497	CbGbCtD
Fluvoxamine—CYP3A4—Mitoxantrone—breast cancer	0.00226	0.00484	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—breast cancer	0.00218	0.00466	CbGbCtD
Fluvoxamine—CYP3A4—Paclitaxel—breast cancer	0.0018	0.00387	CbGbCtD
Fluvoxamine—CYP3A4—Irinotecan—breast cancer	0.00178	0.00381	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—breast cancer	0.00162	0.00348	CbGbCtD
Fluvoxamine—CYP3A4—Vinblastine—breast cancer	0.00158	0.00339	CbGbCtD
Fluvoxamine—ABCB1—Methotrexate—breast cancer	0.00157	0.00337	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—breast cancer	0.00153	0.00328	CbGbCtD
Fluvoxamine—CYP3A4—Docetaxel—breast cancer	0.0013	0.00279	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—breast cancer	0.000973	0.00208	CbGbCtD
Fluvoxamine—SIGMAR1—mammary gland—breast cancer	0.000302	0.059	CbGeAlD
Fluvoxamine—SIGMAR1—nipple—breast cancer	0.000249	0.0488	CbGeAlD
Fluvoxamine—CYP3A7—endocrine gland—breast cancer	0.000197	0.0385	CbGeAlD
Fluvoxamine—CYP2C9—mammary gland—breast cancer	0.000195	0.0381	CbGeAlD
Fluvoxamine—CYP1A2—nipple—breast cancer	0.00017	0.0332	CbGeAlD
Fluvoxamine—CYP1A1—nipple—breast cancer	0.000168	0.0328	CbGeAlD
Fluvoxamine—SIGMAR1—endometrium—breast cancer	0.000151	0.0294	CbGeAlD
Fluvoxamine—SIGMAR1—uterus—breast cancer	0.000139	0.0271	CbGeAlD
Fluvoxamine—SIGMAR1—pituitary gland—breast cancer	0.000136	0.0266	CbGeAlD
Fluvoxamine—SIGMAR1—adipose tissue—breast cancer	0.000136	0.0265	CbGeAlD
Fluvoxamine—SLC6A4—female reproductive system—breast cancer	0.000126	0.0246	CbGeAlD
Fluvoxamine—SIGMAR1—adrenal gland—breast cancer	0.000122	0.0238	CbGeAlD
Fluvoxamine—SIGMAR1—bone marrow—breast cancer	0.000118	0.023	CbGeAlD
Fluvoxamine—SIGMAR1—female gonad—breast cancer	0.000114	0.0222	CbGeAlD
Fluvoxamine—CYP1A1—epithelium—breast cancer	0.000113	0.0221	CbGeAlD
Fluvoxamine—CYP1A1—skin of body—breast cancer	0.000107	0.021	CbGeAlD
Fluvoxamine—SLC6A4—endocrine gland—breast cancer	0.000106	0.0208	CbGeAlD
Fluvoxamine—CYP2B6—skin of body—breast cancer	0.000104	0.0204	CbGeAlD
Fluvoxamine—CYP1A1—uterus—breast cancer	9.33e-05	0.0182	CbGeAlD
Fluvoxamine—CYP1A1—adipose tissue—breast cancer	9.12e-05	0.0178	CbGeAlD
Fluvoxamine—CYP3A5—adipose tissue—breast cancer	8.92e-05	0.0174	CbGeAlD
Fluvoxamine—CYP2C19—endocrine gland—breast cancer	8.81e-05	0.0172	CbGeAlD
Fluvoxamine—CYP1A1—female reproductive system—breast cancer	8.39e-05	0.0164	CbGeAlD
Fluvoxamine—CYP2B6—female reproductive system—breast cancer	8.15e-05	0.0159	CbGeAlD
Fluvoxamine—CYP2C9—female reproductive system—breast cancer	8.07e-05	0.0158	CbGeAlD
Fluvoxamine—CYP2B6—adrenal gland—breast cancer	7.95e-05	0.0155	CbGeAlD
Fluvoxamine—CYP2E1—female reproductive system—breast cancer	7.65e-05	0.015	CbGeAlD
Fluvoxamine—CYP1A1—female gonad—breast cancer	7.63e-05	0.0149	CbGeAlD
Fluvoxamine—CYP2E1—adrenal gland—breast cancer	7.46e-05	0.0146	CbGeAlD
Fluvoxamine—CYP3A5—female gonad—breast cancer	7.46e-05	0.0146	CbGeAlD
Fluvoxamine—SIGMAR1—lymph node—breast cancer	7.3e-05	0.0143	CbGeAlD
Fluvoxamine—CYP1A2—endocrine gland—breast cancer	7.19e-05	0.0141	CbGeAlD
Fluvoxamine—ABCB1—embryo—breast cancer	7.19e-05	0.014	CbGeAlD
Fluvoxamine—CYP1A1—endocrine gland—breast cancer	7.1e-05	0.0139	CbGeAlD
Fluvoxamine—CYP3A5—endocrine gland—breast cancer	6.94e-05	0.0136	CbGeAlD
Fluvoxamine—CYP2B6—endocrine gland—breast cancer	6.9e-05	0.0135	CbGeAlD
Fluvoxamine—CYP2C9—endocrine gland—breast cancer	6.83e-05	0.0134	CbGeAlD
Fluvoxamine—CYP2E1—endocrine gland—breast cancer	6.47e-05	0.0127	CbGeAlD
Fluvoxamine—CYP3A4—female reproductive system—breast cancer	6.15e-05	0.012	CbGeAlD
Fluvoxamine—CYP2D6—female reproductive system—breast cancer	6.06e-05	0.0118	CbGeAlD
Fluvoxamine—ABCB1—epithelium—breast cancer	5.86e-05	0.0115	CbGeAlD
Fluvoxamine—CYP2D6—female gonad—breast cancer	5.51e-05	0.0108	CbGeAlD
Fluvoxamine—ABCB1—endometrium—breast cancer	5.26e-05	0.0103	CbGeAlD
Fluvoxamine—CYP3A4—endocrine gland—breast cancer	5.21e-05	0.0102	CbGeAlD
Fluvoxamine—CYP2D6—endocrine gland—breast cancer	5.12e-05	0.01	CbGeAlD
Fluvoxamine—CYP1A1—lymph node—breast cancer	4.91e-05	0.00959	CbGeAlD
Fluvoxamine—ABCB1—uterus—breast cancer	4.85e-05	0.00947	CbGeAlD
Fluvoxamine—ABCB1—pituitary gland—breast cancer	4.76e-05	0.0093	CbGeAlD
Fluvoxamine—ABCB1—adipose tissue—breast cancer	4.74e-05	0.00927	CbGeAlD
Fluvoxamine—ABCB1—female reproductive system—breast cancer	4.36e-05	0.00852	CbGeAlD
Fluvoxamine—ABCB1—adrenal gland—breast cancer	4.25e-05	0.00831	CbGeAlD
Fluvoxamine—ABCB1—bone marrow—breast cancer	4.11e-05	0.00804	CbGeAlD
Fluvoxamine—ABCB1—female gonad—breast cancer	3.96e-05	0.00775	CbGeAlD
Fluvoxamine—ABCB1—endocrine gland—breast cancer	3.69e-05	0.00721	CbGeAlD
Fluvoxamine—ABCB1—lymph node—breast cancer	2.55e-05	0.00498	CbGeAlD
Fluvoxamine—Dermatitis—Fluorouracil—breast cancer	1.68e-05	9.82e-05	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—breast cancer	1.68e-05	9.81e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Capecitabine—breast cancer	1.67e-05	9.78e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—breast cancer	1.67e-05	9.78e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Paclitaxel—breast cancer	1.67e-05	9.78e-05	CcSEcCtD
Fluvoxamine—Headache—Fluorouracil—breast cancer	1.67e-05	9.77e-05	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—breast cancer	1.67e-05	9.76e-05	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—breast cancer	1.66e-05	9.74e-05	CcSEcCtD
Fluvoxamine—Dysgeusia—Methotrexate—breast cancer	1.66e-05	9.73e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—breast cancer	1.66e-05	9.72e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Capecitabine—breast cancer	1.66e-05	9.72e-05	CcSEcCtD
Fluvoxamine—Fatigue—Docetaxel—breast cancer	1.66e-05	9.7e-05	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—breast cancer	1.66e-05	9.69e-05	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—breast cancer	1.66e-05	9.69e-05	CcSEcCtD
Fluvoxamine—Nausea—Irinotecan—breast cancer	1.65e-05	9.67e-05	CcSEcCtD
Fluvoxamine—Nausea—Mitoxantrone—breast cancer	1.65e-05	9.67e-05	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—breast cancer	1.64e-05	9.62e-05	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—breast cancer	1.64e-05	9.62e-05	CcSEcCtD
Fluvoxamine—Back pain—Methotrexate—breast cancer	1.64e-05	9.61e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Capecitabine—breast cancer	1.64e-05	9.59e-05	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—breast cancer	1.64e-05	9.59e-05	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—breast cancer	1.63e-05	9.55e-05	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—breast cancer	1.63e-05	9.53e-05	CcSEcCtD
Fluvoxamine—Asthenia—Paclitaxel—breast cancer	1.63e-05	9.53e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Capecitabine—breast cancer	1.62e-05	9.47e-05	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—breast cancer	1.61e-05	9.44e-05	CcSEcCtD
Fluvoxamine—Nausea—Gemcitabine—breast cancer	1.61e-05	9.42e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Capecitabine—breast cancer	1.61e-05	9.41e-05	CcSEcCtD
Fluvoxamine—Fatigue—Capecitabine—breast cancer	1.61e-05	9.39e-05	CcSEcCtD
Fluvoxamine—Pruritus—Paclitaxel—breast cancer	1.61e-05	9.39e-05	CcSEcCtD
Fluvoxamine—Vision blurred—Methotrexate—breast cancer	1.6e-05	9.37e-05	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—breast cancer	1.6e-05	9.36e-05	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—breast cancer	1.6e-05	9.35e-05	CcSEcCtD
Fluvoxamine—Constipation—Capecitabine—breast cancer	1.59e-05	9.32e-05	CcSEcCtD
Fluvoxamine—Pain—Capecitabine—breast cancer	1.59e-05	9.32e-05	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—breast cancer	1.59e-05	9.3e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—breast cancer	1.59e-05	9.27e-05	CcSEcCtD
Fluvoxamine—Nausea—Fluorouracil—breast cancer	1.58e-05	9.26e-05	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—breast cancer	1.58e-05	9.24e-05	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Methotrexate—breast cancer	1.58e-05	9.22e-05	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—breast cancer	1.58e-05	9.22e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—breast cancer	1.57e-05	9.2e-05	CcSEcCtD
Fluvoxamine—Anaemia—Methotrexate—breast cancer	1.57e-05	9.19e-05	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—breast cancer	1.57e-05	9.18e-05	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—breast cancer	1.57e-05	9.17e-05	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—breast cancer	1.56e-05	9.13e-05	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—breast cancer	1.56e-05	9.11e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Paclitaxel—breast cancer	1.55e-05	9.09e-05	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—breast cancer	1.54e-05	9.03e-05	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—breast cancer	1.54e-05	9e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Capecitabine—breast cancer	1.53e-05	8.98e-05	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—breast cancer	1.53e-05	8.97e-05	CcSEcCtD
Fluvoxamine—Malaise—Methotrexate—breast cancer	1.53e-05	8.96e-05	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—breast cancer	1.53e-05	8.94e-05	CcSEcCtD
Fluvoxamine—Vertigo—Methotrexate—breast cancer	1.53e-05	8.93e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Capecitabine—breast cancer	1.52e-05	8.91e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—breast cancer	1.52e-05	8.9e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—breast cancer	1.52e-05	8.9e-05	CcSEcCtD
Fluvoxamine—Leukopenia—Methotrexate—breast cancer	1.52e-05	8.9e-05	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—breast cancer	1.52e-05	8.87e-05	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—breast cancer	1.51e-05	8.83e-05	CcSEcCtD
Fluvoxamine—Dizziness—Paclitaxel—breast cancer	1.5e-05	8.78e-05	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—breast cancer	1.5e-05	8.77e-05	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—breast cancer	1.49e-05	8.74e-05	CcSEcCtD
Fluvoxamine—Cough—Methotrexate—breast cancer	1.48e-05	8.67e-05	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—breast cancer	1.48e-05	8.66e-05	CcSEcCtD
Fluvoxamine—Urticaria—Capecitabine—breast cancer	1.48e-05	8.66e-05	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—breast cancer	1.48e-05	8.63e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Capecitabine—breast cancer	1.47e-05	8.61e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Capecitabine—breast cancer	1.47e-05	8.61e-05	CcSEcCtD
Fluvoxamine—Convulsion—Methotrexate—breast cancer	1.47e-05	8.61e-05	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—breast cancer	1.47e-05	8.61e-05	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—breast cancer	1.47e-05	8.6e-05	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—breast cancer	1.46e-05	8.55e-05	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—breast cancer	1.45e-05	8.48e-05	CcSEcCtD
Fluvoxamine—Chest pain—Methotrexate—breast cancer	1.45e-05	8.46e-05	CcSEcCtD
Fluvoxamine—Arthralgia—Methotrexate—breast cancer	1.45e-05	8.46e-05	CcSEcCtD
Fluvoxamine—Myalgia—Methotrexate—breast cancer	1.45e-05	8.46e-05	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—breast cancer	1.44e-05	8.45e-05	CcSEcCtD
Fluvoxamine—Vomiting—Paclitaxel—breast cancer	1.44e-05	8.44e-05	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—breast cancer	1.44e-05	8.43e-05	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—breast cancer	1.43e-05	8.39e-05	CcSEcCtD
Fluvoxamine—Rash—Paclitaxel—breast cancer	1.43e-05	8.37e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Paclitaxel—breast cancer	1.43e-05	8.36e-05	CcSEcCtD
Fluvoxamine—Discomfort—Methotrexate—breast cancer	1.43e-05	8.36e-05	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—breast cancer	1.43e-05	8.36e-05	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—breast cancer	1.43e-05	8.36e-05	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—breast cancer	1.43e-05	8.34e-05	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—breast cancer	1.42e-05	8.33e-05	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—breast cancer	1.42e-05	8.33e-05	CcSEcCtD
Fluvoxamine—Headache—Paclitaxel—breast cancer	1.42e-05	8.32e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—breast cancer	1.42e-05	8.29e-05	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—breast cancer	1.41e-05	8.27e-05	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—breast cancer	1.4e-05	8.22e-05	CcSEcCtD
Fluvoxamine—Confusional state—Methotrexate—breast cancer	1.4e-05	8.18e-05	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—breast cancer	1.4e-05	8.18e-05	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—breast cancer	1.39e-05	8.12e-05	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Methotrexate—breast cancer	1.39e-05	8.11e-05	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—breast cancer	1.39e-05	8.11e-05	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—breast cancer	1.38e-05	8.08e-05	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—breast cancer	1.38e-05	8.06e-05	CcSEcCtD
Fluvoxamine—Infection—Methotrexate—breast cancer	1.38e-05	8.06e-05	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—breast cancer	1.37e-05	8.03e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Capecitabine—breast cancer	1.37e-05	8.03e-05	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—breast cancer	1.36e-05	7.99e-05	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—breast cancer	1.36e-05	7.96e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methotrexate—breast cancer	1.36e-05	7.96e-05	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—breast cancer	1.36e-05	7.95e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Methotrexate—breast cancer	1.36e-05	7.94e-05	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—breast cancer	1.35e-05	7.92e-05	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—breast cancer	1.35e-05	7.92e-05	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—breast cancer	1.35e-05	7.92e-05	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—breast cancer	1.35e-05	7.91e-05	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—breast cancer	1.35e-05	7.89e-05	CcSEcCtD
Fluvoxamine—Nausea—Paclitaxel—breast cancer	1.35e-05	7.89e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methotrexate—breast cancer	1.34e-05	7.84e-05	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—breast cancer	1.34e-05	7.82e-05	CcSEcCtD
Fluvoxamine—Asthenia—Capecitabine—breast cancer	1.34e-05	7.82e-05	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—breast cancer	1.33e-05	7.76e-05	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—breast cancer	1.32e-05	7.74e-05	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—breast cancer	1.32e-05	7.73e-05	CcSEcCtD
Fluvoxamine—Anorexia—Methotrexate—breast cancer	1.32e-05	7.73e-05	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—breast cancer	1.32e-05	7.72e-05	CcSEcCtD
Fluvoxamine—Pruritus—Capecitabine—breast cancer	1.32e-05	7.71e-05	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—breast cancer	1.32e-05	7.7e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—breast cancer	1.32e-05	7.7e-05	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—breast cancer	1.31e-05	7.65e-05	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—breast cancer	1.3e-05	7.61e-05	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—breast cancer	1.3e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—breast cancer	1.3e-05	7.59e-05	CcSEcCtD
Fluvoxamine—Hypotension—Methotrexate—breast cancer	1.3e-05	7.58e-05	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—breast cancer	1.29e-05	7.56e-05	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—breast cancer	1.29e-05	7.54e-05	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—breast cancer	1.28e-05	7.51e-05	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—breast cancer	1.28e-05	7.47e-05	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—breast cancer	1.27e-05	7.46e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Capecitabine—breast cancer	1.27e-05	7.46e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—breast cancer	1.27e-05	7.44e-05	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—breast cancer	1.27e-05	7.44e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—breast cancer	1.27e-05	7.43e-05	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—breast cancer	1.27e-05	7.43e-05	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—breast cancer	1.27e-05	7.41e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methotrexate—breast cancer	1.26e-05	7.39e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—breast cancer	1.25e-05	7.34e-05	CcSEcCtD
Fluvoxamine—Insomnia—Methotrexate—breast cancer	1.25e-05	7.34e-05	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—breast cancer	1.25e-05	7.33e-05	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—breast cancer	1.25e-05	7.33e-05	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—breast cancer	1.25e-05	7.33e-05	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—breast cancer	1.25e-05	7.3e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Methotrexate—breast cancer	1.24e-05	7.28e-05	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—breast cancer	1.24e-05	7.24e-05	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—breast cancer	1.24e-05	7.24e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Methotrexate—breast cancer	1.24e-05	7.23e-05	CcSEcCtD
Fluvoxamine—Somnolence—Methotrexate—breast cancer	1.23e-05	7.21e-05	CcSEcCtD
Fluvoxamine—Dizziness—Capecitabine—breast cancer	1.23e-05	7.21e-05	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—breast cancer	1.22e-05	7.17e-05	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—breast cancer	1.22e-05	7.16e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Methotrexate—breast cancer	1.22e-05	7.14e-05	CcSEcCtD
Fluvoxamine—Rash—Docetaxel—breast cancer	1.21e-05	7.1e-05	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—breast cancer	1.21e-05	7.09e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—breast cancer	1.21e-05	7.09e-05	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—breast cancer	1.21e-05	7.08e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Methotrexate—breast cancer	1.21e-05	7.05e-05	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—breast cancer	1.21e-05	7.05e-05	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—breast cancer	1.2e-05	7.02e-05	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—breast cancer	1.2e-05	7.02e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Methotrexate—breast cancer	1.2e-05	7e-05	CcSEcCtD
Fluvoxamine—Fatigue—Methotrexate—breast cancer	1.2e-05	6.99e-05	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—breast cancer	1.19e-05	6.98e-05	CcSEcCtD
Fluvoxamine—Pain—Methotrexate—breast cancer	1.19e-05	6.94e-05	CcSEcCtD
Fluvoxamine—Vomiting—Capecitabine—breast cancer	1.18e-05	6.93e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.18e-05	6.92e-05	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—breast cancer	1.18e-05	6.91e-05	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—breast cancer	1.18e-05	6.89e-05	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—breast cancer	1.18e-05	6.88e-05	CcSEcCtD
Fluvoxamine—Rash—Capecitabine—breast cancer	1.17e-05	6.87e-05	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—breast cancer	1.17e-05	6.87e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Capecitabine—breast cancer	1.17e-05	6.86e-05	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—breast cancer	1.17e-05	6.86e-05	CcSEcCtD
Fluvoxamine—Headache—Capecitabine—breast cancer	1.17e-05	6.83e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—breast cancer	1.17e-05	6.82e-05	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—breast cancer	1.16e-05	6.79e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—breast cancer	1.16e-05	6.77e-05	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—breast cancer	1.15e-05	6.75e-05	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—breast cancer	1.14e-05	6.7e-05	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—breast cancer	1.14e-05	6.69e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methotrexate—breast cancer	1.14e-05	6.68e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—breast cancer	1.14e-05	6.68e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methotrexate—breast cancer	1.13e-05	6.63e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—breast cancer	1.13e-05	6.6e-05	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—breast cancer	1.12e-05	6.56e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—breast cancer	1.12e-05	6.55e-05	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—breast cancer	1.12e-05	6.55e-05	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—breast cancer	1.11e-05	6.49e-05	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—breast cancer	1.11e-05	6.49e-05	CcSEcCtD
Fluvoxamine—Nausea—Capecitabine—breast cancer	1.11e-05	6.47e-05	CcSEcCtD
Fluvoxamine—Urticaria—Methotrexate—breast cancer	1.1e-05	6.44e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Methotrexate—breast cancer	1.1e-05	6.41e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Methotrexate—breast cancer	1.1e-05	6.41e-05	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.09e-05	6.4e-05	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—breast cancer	1.09e-05	6.35e-05	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—breast cancer	1.08e-05	6.31e-05	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—breast cancer	1.07e-05	6.26e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—breast cancer	1.07e-05	6.26e-05	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—breast cancer	1.07e-05	6.24e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—breast cancer	1.06e-05	6.21e-05	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—breast cancer	1.06e-05	6.18e-05	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—breast cancer	1.04e-05	6.11e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.04e-05	6.06e-05	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—breast cancer	1.04e-05	6.06e-05	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—breast cancer	1.03e-05	6.03e-05	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—breast cancer	1.03e-05	6.01e-05	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—breast cancer	1.03e-05	6.01e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—breast cancer	1.03e-05	6e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—breast cancer	1.03e-05	6e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methotrexate—breast cancer	1.02e-05	5.98e-05	CcSEcCtD
Fluvoxamine—Asthenia—Methotrexate—breast cancer	9.95e-06	5.82e-05	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—breast cancer	9.89e-06	5.79e-05	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—breast cancer	9.82e-06	5.74e-05	CcSEcCtD
Fluvoxamine—Pruritus—Methotrexate—breast cancer	9.81e-06	5.74e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—breast cancer	9.56e-06	5.59e-05	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—breast cancer	9.54e-06	5.58e-05	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—breast cancer	9.49e-06	5.55e-05	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—breast cancer	9.49e-06	5.55e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Methotrexate—breast cancer	9.49e-06	5.55e-05	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—breast cancer	9.31e-06	5.45e-05	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—breast cancer	9.18e-06	5.37e-05	CcSEcCtD
Fluvoxamine—Dizziness—Methotrexate—breast cancer	9.17e-06	5.36e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—breast cancer	8.88e-06	5.19e-05	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—breast cancer	8.84e-06	5.18e-05	CcSEcCtD
Fluvoxamine—Vomiting—Methotrexate—breast cancer	8.81e-06	5.16e-05	CcSEcCtD
Fluvoxamine—Rash—Methotrexate—breast cancer	8.74e-06	5.11e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Methotrexate—breast cancer	8.73e-06	5.11e-05	CcSEcCtD
Fluvoxamine—Headache—Methotrexate—breast cancer	8.69e-06	5.08e-05	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—breast cancer	8.61e-06	5.04e-05	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—breast cancer	8.58e-06	5.02e-05	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—breast cancer	8.49e-06	4.97e-05	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—breast cancer	8.25e-06	4.83e-05	CcSEcCtD
Fluvoxamine—Nausea—Methotrexate—breast cancer	8.23e-06	4.82e-05	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—breast cancer	8.21e-06	4.81e-05	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—breast cancer	8.18e-06	4.79e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—breast cancer	8.17e-06	4.78e-05	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—breast cancer	8.13e-06	4.76e-05	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—breast cancer	7.94e-06	4.64e-05	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—breast cancer	7.71e-06	4.51e-05	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—breast cancer	7.63e-06	4.47e-05	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—breast cancer	7.57e-06	4.43e-05	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—breast cancer	7.56e-06	4.42e-05	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—breast cancer	7.52e-06	4.4e-05	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—breast cancer	7.13e-06	4.17e-05	CcSEcCtD
Fluvoxamine—ABCB1—Metabolism—STK11—breast cancer	2.37e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP19A1—breast cancer	2.37e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ENO1—breast cancer	2.37e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS1—breast cancer	2.37e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—breast cancer	2.37e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—breast cancer	2.36e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.36e-06	3.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1B1—breast cancer	2.36e-06	3.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.33e-06	3.18e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.33e-06	3.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2D6—breast cancer	2.32e-06	3.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.31e-06	3.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.28e-06	3.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NCOA2—breast cancer	2.28e-06	3.11e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—breast cancer	2.28e-06	3.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NCOA1—breast cancer	2.27e-06	3.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—COMT—breast cancer	2.26e-06	3.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTP1—breast cancer	2.25e-06	3.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NCOA1—breast cancer	2.25e-06	3.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.24e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—STK11—breast cancer	2.24e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—breast cancer	2.23e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAV1—breast cancer	2.23e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—breast cancer	2.22e-06	3.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP19A1—breast cancer	2.22e-06	3.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—STK11—breast cancer	2.22e-06	3.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ITPR1—breast cancer	2.21e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—FASN—breast cancer	2.21e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DPYD—breast cancer	2.21e-06	3e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MED12—breast cancer	2.21e-06	3e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—COMT—breast cancer	2.2e-06	3e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—BCHE—breast cancer	2.2e-06	3e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTP1—breast cancer	2.19e-06	2.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAV1—breast cancer	2.18e-06	2.97e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAV1—breast cancer	2.18e-06	2.97e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC5A5—breast cancer	2.17e-06	2.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDOA—breast cancer	2.17e-06	2.96e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—breast cancer	2.16e-06	2.95e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ITPR1—breast cancer	2.16e-06	2.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCB1—breast cancer	2.13e-06	2.9e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOA3—breast cancer	2.11e-06	2.87e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CB—breast cancer	2.1e-06	2.87e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC2A1—breast cancer	2.1e-06	2.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NQO1—breast cancer	2.1e-06	2.86e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.09e-06	2.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TYMS—breast cancer	2.09e-06	2.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—breast cancer	2.08e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.08e-06	2.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—COMT—breast cancer	2.08e-06	2.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTP1—breast cancer	2.07e-06	2.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NCOR1—breast cancer	2.07e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—breast cancer	2.07e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.07e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—COMT—breast cancer	2.06e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—breast cancer	2.06e-06	2.8e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.06e-06	2.8e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CPT1A—breast cancer	2.05e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCG2—breast cancer	2.05e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTR—breast cancer	2.05e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTP1—breast cancer	2.05e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP3A4—breast cancer	2.05e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TYMS—breast cancer	2.04e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—breast cancer	2.04e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.04e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ITPR1—breast cancer	2.03e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CG—breast cancer	2.03e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—breast cancer	2.02e-06	2.75e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ITPR1—breast cancer	2.02e-06	2.75e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PLA2G4A—breast cancer	2.02e-06	2.75e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NCOR1—breast cancer	2.02e-06	2.75e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—breast cancer	2.02e-06	2.75e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1B1—breast cancer	2.01e-06	2.74e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HPGDS—breast cancer	2.01e-06	2.74e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HBA1—breast cancer	2e-06	2.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CG—breast cancer	1.99e-06	2.71e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CG—breast cancer	1.98e-06	2.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—breast cancer	1.98e-06	2.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.97e-06	2.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.97e-06	2.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1A1—breast cancer	1.96e-06	2.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCB1—breast cancer	1.96e-06	2.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ACHE—breast cancer	1.95e-06	2.66e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTT1—breast cancer	1.95e-06	2.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ERCC2—breast cancer	1.94e-06	2.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCB1—breast cancer	1.94e-06	2.64e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—breast cancer	1.93e-06	2.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TYMS—breast cancer	1.92e-06	2.62e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NCOA1—breast cancer	1.92e-06	2.62e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1A1—breast cancer	1.91e-06	2.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TYMS—breast cancer	1.91e-06	2.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.9e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NCOR1—breast cancer	1.9e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—breast cancer	1.9e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ERCC2—breast cancer	1.9e-06	2.58e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—STK11—breast cancer	1.89e-06	2.58e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP19A1—breast cancer	1.89e-06	2.58e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.88e-06	2.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—breast cancer	1.88e-06	2.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NCOR1—breast cancer	1.88e-06	2.57e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CG—breast cancer	1.87e-06	2.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.85e-06	2.51e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ENO1—breast cancer	1.83e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS1—breast cancer	1.83e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—breast cancer	1.83e-06	2.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—breast cancer	1.82e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—breast cancer	1.82e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—breast cancer	1.8e-06	2.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.8e-06	2.45e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.79e-06	2.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ERCC2—breast cancer	1.79e-06	2.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1A1—breast cancer	1.79e-06	2.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CD—breast cancer	1.78e-06	2.43e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—breast cancer	1.78e-06	2.43e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.78e-06	2.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ERCC2—breast cancer	1.77e-06	2.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—breast cancer	1.76e-06	2.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—COMT—breast cancer	1.76e-06	2.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOA2—breast cancer	1.76e-06	2.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTP1—breast cancer	1.75e-06	2.39e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CD—breast cancer	1.75e-06	2.38e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CD—breast cancer	1.74e-06	2.38e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—breast cancer	1.73e-06	2.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—breast cancer	1.73e-06	2.35e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ITPR1—breast cancer	1.72e-06	2.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—breast cancer	1.72e-06	2.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FASN—breast cancer	1.71e-06	2.32e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BCHE—breast cancer	1.7e-06	2.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—breast cancer	1.69e-06	2.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—breast cancer	1.68e-06	2.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—breast cancer	1.68e-06	2.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.68e-06	2.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—breast cancer	1.67e-06	2.27e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCB1—breast cancer	1.66e-06	2.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—breast cancer	1.65e-06	2.25e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CD—breast cancer	1.65e-06	2.24e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—breast cancer	1.65e-06	2.24e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—breast cancer	1.64e-06	2.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TYMS—breast cancer	1.63e-06	2.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—breast cancer	1.63e-06	2.22e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.62e-06	2.21e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NQO1—breast cancer	1.62e-06	2.21e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NCOR1—breast cancer	1.61e-06	2.19e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.61e-06	2.19e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—breast cancer	1.61e-06	2.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.61e-06	2.19e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—breast cancer	1.56e-06	2.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.56e-06	2.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.55e-06	2.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—breast cancer	1.55e-06	2.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—breast cancer	1.54e-06	2.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—breast cancer	1.54e-06	2.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—breast cancer	1.54e-06	2.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CG—breast cancer	1.53e-06	2.09e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.53e-06	2.08e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.52e-06	2.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.52e-06	2.08e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CB—breast cancer	1.52e-06	2.07e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ERCC2—breast cancer	1.51e-06	2.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—breast cancer	1.51e-06	2.06e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—breast cancer	1.51e-06	2.05e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CG—breast cancer	1.5e-06	2.04e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOA1—breast cancer	1.48e-06	2.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.47e-06	2e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—STK11—breast cancer	1.46e-06	1.99e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.46e-06	1.99e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CB—breast cancer	1.44e-06	1.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—breast cancer	1.42e-06	1.94e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—breast cancer	1.42e-06	1.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.41e-06	1.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.4e-06	1.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—COMT—breast cancer	1.36e-06	1.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTP1—breast cancer	1.35e-06	1.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.35e-06	1.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—breast cancer	1.34e-06	1.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—breast cancer	1.33e-06	1.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—breast cancer	1.33e-06	1.81e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ITPR1—breast cancer	1.33e-06	1.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—breast cancer	1.32e-06	1.79e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CD—breast cancer	1.32e-06	1.79e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—breast cancer	1.31e-06	1.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—breast cancer	1.31e-06	1.79e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—breast cancer	1.3e-06	1.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—breast cancer	1.28e-06	1.75e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCB1—breast cancer	1.28e-06	1.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—breast cancer	1.27e-06	1.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TYMS—breast cancer	1.26e-06	1.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.25e-06	1.71e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—breast cancer	1.24e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—breast cancer	1.24e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOR1—breast cancer	1.24e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.24e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—breast cancer	1.24e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.24e-06	1.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.23e-06	1.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—breast cancer	1.22e-06	1.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—breast cancer	1.21e-06	1.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.2e-06	1.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—breast cancer	1.19e-06	1.62e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.18e-06	1.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.18e-06	1.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—breast cancer	1.17e-06	1.6e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ERCC2—breast cancer	1.17e-06	1.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—breast cancer	1.16e-06	1.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—breast cancer	1.16e-06	1.58e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CB—breast cancer	1.15e-06	1.56e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—breast cancer	1.14e-06	1.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—breast cancer	1.1e-06	1.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.08e-06	1.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.07e-06	1.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—breast cancer	1.07e-06	1.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—breast cancer	1.06e-06	1.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.05e-06	1.43e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—breast cancer	1.05e-06	1.43e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—breast cancer	1.04e-06	1.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—breast cancer	1.02e-06	1.38e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—breast cancer	1.01e-06	1.38e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—breast cancer	9.92e-07	1.35e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—breast cancer	9.92e-07	1.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—breast cancer	9.48e-07	1.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—breast cancer	9.34e-07	1.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—breast cancer	9.29e-07	1.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—breast cancer	9.27e-07	1.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—breast cancer	9.26e-07	1.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CG—breast cancer	9.23e-07	1.26e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CB—breast cancer	9.16e-07	1.25e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—breast cancer	9.08e-07	1.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—breast cancer	8.76e-07	1.19e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CD—breast cancer	8.11e-07	1.1e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—breast cancer	8.01e-07	1.09e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—breast cancer	7.92e-07	1.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—breast cancer	7.75e-07	1.06e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—breast cancer	7.66e-07	1.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—breast cancer	7.59e-07	1.03e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—breast cancer	7.57e-07	1.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—breast cancer	7.17e-07	9.76e-06	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—breast cancer	7.15e-07	9.74e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CB—breast cancer	7.07e-07	9.63e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—breast cancer	7e-07	9.54e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—breast cancer	6.99e-07	9.53e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—breast cancer	6.59e-07	8.98e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—breast cancer	6.53e-07	8.9e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—breast cancer	6.11e-07	8.32e-06	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—breast cancer	5.85e-07	7.97e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—breast cancer	5.71e-07	7.78e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—breast cancer	5.58e-07	7.61e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—breast cancer	5.38e-07	7.33e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—breast cancer	5.34e-07	7.27e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—breast cancer	4.56e-07	6.21e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—breast cancer	4.31e-07	5.87e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—breast cancer	3.52e-07	4.79e-06	CbGpPWpGaD
